Association of Plasma Uremic Solute Levels with Residual Kidney Function in Children on Peritoneal Dialysis

Author(s):  
Lakshmi Ganesan ◽  
Frank O'Brien ◽  
Tammy Sirich ◽  
Natalie Plummer ◽  
Rita Sheth ◽  
...  

Background and objectives. Residual native kidney function confers health benefits in dialysis patients. It can facilitate control of extracellular volume and inorganic ion concentrations. Residual kidney function can also limit the accumulation of uremic solutes. This study assessed whether lower plasma concentrations of uremic solutes were associated with residual kidney function in pediatric patients on peritoneal dialysis. Design, setting, participants, and measurements. Samples were analyzed from 29 pediatric peritoneal dialysis patients including 13 without residual kidney function and 10 with residual kidney function. Metabolomic analysis by untargeted mass spectrometry compared plasma solute levels in patients with and without residual kidney function. Dialytic and residual clearances of selected solutes were also measured by assays employing chemical standards. Results. Metabolomic analysis showed that plasma levels of 256 uremic solutes in patients with residual kidney function averaged 64 (51-81 IQR) percent of the values in patients without residual kidney function who had similar total Kt/Vurea. The plasma levels were significantly lower for 59 of the 256 solutes in the patients with residual kidney function and significantly higher for none. Assays employing chemical standards showed that residual kidney function provides a higher portion of the total clearance for non-urea solutes than it does for urea. Conclusions. Concentrations of many uremic solutes are lower in peritoneal dialysis patients with residual kidney function than in those without residual kidney function receiving similar treatment as assessed by Kt/Vurea.

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Sirayut Phatthanasobhon ◽  
Surapon Nochaiwong ◽  
Kednapa Thavorn ◽  
Kajohnsak Noppakun ◽  
Setthapon Panyathong ◽  
...  

AbstractWe performed a network meta-analysis of randomised controlled trials (RCTs) and non-randomised studies in adult peritoneal dialysis patients to evaluate the effects of specific renin-angiotensin aldosterone systems (RAAS) blockade classes on residual kidney function and peritoneal membrane function. Key outcome parameters included the following: residual glomerular filtration rate (rGFR), urine volume, anuria, dialysate-to-plasma creatinine ratio (D/P Cr), and acceptability of treatment. Indirect treatment effects were compared using random-effects model. Pooled standardised mean differences (SMDs) and odd ratios (ORs) were estimated with 95% confidence intervals (CIs). We identified 10 RCTs (n = 484) and 10 non-randomised studies (n = 3,305). Regarding changes in rGFR, RAAS blockade with angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) were more efficacious than active control (SMD 0.55 [0.06–1.04] and 0.62 [0.19–1.04], respectively) with the protective effect on rGFR observed only after usage ≥12 months, and no differences among ACEIs and ARBs. Compared with active control, only ACEIs showed a significantly decreased risk of anuria (OR 0.62 [0.41–0.95]). No difference among treatments for urine volume and acceptability of treatment were observed, whereas evidence for D/P Cr is inconclusive. The small number of randomised studies and differences in outcome definitions used may limit the quality of the evidence.


2011 ◽  
Vol 44 (9) ◽  
pp. 939-944
Author(s):  
Atsushi Saito ◽  
Tsutomu Tabata ◽  
Yoshihiro Tsujimoto ◽  
Yuko Fujiwara ◽  
Yuka Hosomi ◽  
...  

PLoS ONE ◽  
2016 ◽  
Vol 11 (7) ◽  
pp. e0158696 ◽  
Author(s):  
Miguel Pérez Fontán ◽  
César Remón Rodríguez ◽  
Marta da Cunha Naveira ◽  
Mercè Borràs Sans ◽  
Carmen Rodríguez Suárez ◽  
...  

2004 ◽  
Vol 43 (4) ◽  
pp. 712-720 ◽  
Author(s):  
Angela Yee-Moon Wang ◽  
Jean Woo ◽  
Mandy Man-Mei Sea ◽  
Man-Ching Law ◽  
Siu-Fai Lui ◽  
...  

2018 ◽  
Vol 71 (6) ◽  
pp. 802-813 ◽  
Author(s):  
Yoshitsugu Obi ◽  
Elani Streja ◽  
Rajnish Mehrotra ◽  
Matthew B. Rivara ◽  
Connie M. Rhee ◽  
...  

2019 ◽  
pp. 201-208
Author(s):  
Miten J. Dhruve ◽  
Joanne M. Bargman ◽  
Joanne M. Bargman

Residual kidney function is strongly associated with benefits in survival, morbidity, and quality of life in both hemodialysis and peritoneal dialysis patients. Possible explanations include better volume control in dialysis patients who maintain significant urine volume, better middle molecule and other toxin clearance by the kidneys, and a lower level of systemic inflammation associated with ongoing kidney function. The residual kidney function should be monitored and preserved if at all possible. Practices such as incremental dialysis, avoidance of interim hemodialysis in those choosing peritoneal dialysis, avoidance of peritonitis and nephrotoxic medications, use of renin–angiotensin–aldosterone system blockade, and maintenance of transplant kidney function with ongoing low-level immunosuppression are all methods that can be implemented to help protect this vital function.


2019 ◽  
Vol 24 (2) ◽  
pp. 202-207
Author(s):  
Hiroaki Tsujikawa ◽  
Shigeru Tanaka ◽  
Masatoshi Hara ◽  
Yasuhiro Kawai ◽  
Yuta Matsukuma ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document